Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 28, 2023

Investigational Drug Information for Ceftobiprole

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the drug development status for Ceftobiprole?

Ceftobiprole is an investigational drug.

There have been 22 clinical trials for Ceftobiprole. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1^st 2005.

The most common disease conditions in clinical trials are Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Basilea Pharmaceutica, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., and Department of Health and Human Services.

Summary for Ceftobiprole

US Patents	0
International Patents	0
US Patent Applications	2,304
WIPO Patent Applications	1,345
Japanese Patent Applications	2
Clinical Trial Progress	Phase 3 (2005-09-01)
Vendors	26

Recent Clinical Trials for Ceftobiprole

Title	Sponsor	Phase
Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age	Basilea Pharmaceutica	Phase 3
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.	Centre Hospitalier Lyon Sud	N/A
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.	CHU de Nîmes	N/A

See all Ceftobiprole clinical trials

Clinical Trial Summary for Ceftobiprole

Top disease conditions for Ceftobiprole

Top clinical trial sponsors for Ceftobiprole

See all Ceftobiprole clinical trials

US Patents for Ceftobiprole

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Johnson and Johnson

Baxter

Boehringer Ingelheim

Moodys

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.